Ampio Total Debt vs Total Assets Per Share Analysis
AMPE Stock | USD 0.92 0.10 12.20% |
Trend analysis of Ampio Pharm balance sheet accounts such as Other Current Liab of 1.5 M, Total Current Liabilities of 2.6 M or Total Stockholder Equity of 3.2 M provides information on Ampio Pharm's total assets, liabilities, and equity, which is the actual value of Ampio Pharm to its prevalent stockholders. By breaking down trends over time using Ampio Pharm balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Ampio |
About Ampio Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Ampio Pharm at a specified time, usually calculated after every quarter, six months, or one year. Ampio Pharm Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ampio Pharm and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ampio currently owns. An asset can also be divided into two categories, current and non-current.
Ampio Pharm Balance Sheet Chart
Ampio Pharm Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Ampio Pharm uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, Ampio Pharm's Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 27.8 K, whereas Other Current Liabilities is forecasted to decline to about 1.5 M. Add Fundamental
Total Assets
Total assets refers to the total amount of Ampio Pharm assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Ampio Pharm books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Ampio Pharm balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Ampio Pharm are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Most indicators from Ampio Pharm's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ampio Pharm current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ampio Pharm. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Ampio Stock refer to our How to Trade Ampio Stock guide.The current year's Enterprise Value Multiple is expected to grow to 0.26, whereas Selling General Administrative is forecasted to decline to about 6.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Research Development | 11.9M | 8.9M | 2.4M | 2.3M | Cost Of Revenue | 1.1M | 2.1M | 1.9M | 3.5M |
Ampio Pharm fundamental ratios Correlations
Click cells to compare fundamentals
Ampio Pharm Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ampio Pharm fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 14.0M | 22.9M | 38.8M | 13.6M | 5.7M | 5.4M | |
Other Current Liab | 3.9M | 1.4M | 4.4M | 755K | 2.1M | 1.5M | |
Total Current Liabilities | 4.3M | 1.8M | 5.1M | 1.2M | 2.4M | 2.6M | |
Total Stockholder Equity | 6.4M | 17.5M | 27.3M | 11.8M | 3.4M | 3.2M | |
Retained Earnings | (184.6M) | (200.5M) | (217.6M) | (233.9M) | (242.5M) | (230.4M) | |
Non Current Assets Total | 5.8M | 4.4M | 3.2M | 259K | 297.9K | 283.0K | |
Common Stock Total Equity | 11.1K | 16K | 19K | 23K | 26.5K | 27.8K | |
Common Stock Shares Outstanding | 474.0K | 595.4K | 671.5K | 753.6K | 810.1K | 889.4K | |
Liabilities And Stockholders Equity | 14.0M | 22.9M | 38.8M | 13.6M | 5.7M | 5.4M | |
Other Stockholder Equity | 191.1M | 218.0M | 244.9M | 245.7M | 245.9M | 135.4M | |
Total Liab | 7.6M | 5.4M | 11.5M | 1.8M | 2.4M | 2.3M | |
Common Stock | 16K | 19K | 23K | 2K | 1.8K | 1.7K | |
Net Debt | (5.1M) | (16.1M) | (33.0M) | (12.0M) | (3.8M) | (4.0M) | |
Accounts Payable | 151K | 186K | 427K | 97K | 111.6K | 106.0K | |
Cash | 6.5M | 17.3M | 33.9M | 12.7M | 4.1M | 3.9M | |
Cash And Short Term Investments | 6.5M | 17.3M | 33.9M | 12.7M | 4.1M | 3.9M | |
Total Current Assets | 8.3M | 18.5M | 35.6M | 13.3M | 5.7M | 5.4M | |
Other Current Assets | 556K | 696K | 533K | 623K | 1.6M | 1.7M | |
Other Liab | 2.1M | 2.6M | 5.8M | 333K | 383.0K | 363.8K | |
Net Tangible Assets | 6.4M | 17.5M | 27.3M | 11.8M | 10.6M | 12.4M | |
Property Plant And Equipment Net | 5.8M | 4.4M | 3.2M | 259K | 297.9K | 283.0K | |
Retained Earnings Total Equity | (171.0M) | (184.6M) | (200.5M) | (217.6M) | (195.8M) | (186.0M) | |
Non Current Liabilities Total | 3.3M | 3.5M | 6.4M | 607K | 698.1K | 663.1K | |
Capital Surpluse | 176.2M | 191.1M | 218.0M | 244.9M | 281.6M | 170.7M | |
Deferred Long Term Liab | 7.4M | 2.1M | 2.6M | 5.8M | 6.7M | 7.1M | |
Property Plant And Equipment Gross | 5.8M | 4.4M | 3.2M | 9.5M | 10.9M | 5.9M | |
Property Plant Equipment | 4.7M | 3.6M | 2.6M | 259K | 297.9K | 283.0K | |
Net Invested Capital | 6.4M | 17.5M | 27.3M | 11.8M | 13.6M | 14.2M | |
Net Working Capital | 4.0M | 16.7M | 30.5M | 12.1M | 14.0M | 13.6M |
Pair Trading with Ampio Pharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ampio Pharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ampio Pharm will appreciate offsetting losses from the drop in the long position's value.Moving against Ampio Stock
0.6 | DNTH | Dianthus Therapeutics Symbol Change | PairCorr |
0.55 | MESO | Mesoblast Trending | PairCorr |
0.52 | MRK | Merck Company Fiscal Quarter End 31st of March 2024 | PairCorr |
0.49 | MDWD | Mediwound Downward Rally | PairCorr |
0.44 | TCRX | Tscan Therapeutics Financial Report 8th of May 2024 | PairCorr |
The ability to find closely correlated positions to Ampio Pharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ampio Pharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ampio Pharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ampio Pharm to buy it.
The correlation of Ampio Pharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ampio Pharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ampio Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ampio Pharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ampio Pharm. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Ampio Stock refer to our How to Trade Ampio Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Ampio Stock analysis
When running Ampio Pharm's price analysis, check to measure Ampio Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ampio Pharm is operating at the current time. Most of Ampio Pharm's value examination focuses on studying past and present price action to predict the probability of Ampio Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ampio Pharm's price. Additionally, you may evaluate how the addition of Ampio Pharm to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Stocks Directory Find actively traded stocks across global markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is Ampio Pharm's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ampio Pharm. If investors know Ampio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ampio Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.70) | Return On Assets (0.47) | Return On Equity (0.92) |
The market value of Ampio Pharm is measured differently than its book value, which is the value of Ampio that is recorded on the company's balance sheet. Investors also form their own opinion of Ampio Pharm's value that differs from its market value or its book value, called intrinsic value, which is Ampio Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ampio Pharm's market value can be influenced by many factors that don't directly affect Ampio Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ampio Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ampio Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ampio Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.